» Authors » GoEun Yang

GoEun Yang

Explore the profile of GoEun Yang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 264
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Smolen J, Trefler J, Racewicz A, Jaworski J, Zielinska A, Krogulec M, et al.
RMD Open . 2024 Oct; 10(4). PMID: 39424404
Objectives: To demonstrate efficacy equivalence of CT-P47 and EU-approved reference tocilizumab (r-TCZ) in patients with rheumatoid arthritis (RA). Methods: This double-blind, phase III study randomised (1:1) patients to receive CT-P47...
2.
Haranaka M, Eto T, Tanaka T, Yazawa R, Burmester G, Keystone E, et al.
J Clin Pharmacol . 2024 Oct; 65(2):233-241. PMID: 39415551
CT-P47 is a candidate biosimilar of tocilizumab. This 12-week, randomized, double-blind, parallel-design, phase 1 study aimed to demonstrate pharmacokinetic (PK) equivalence of CT-P47 and reference tocilizumab. Participants were healthy Japanese...
3.
Yu K, Ryu H, Shin D, Park M, Hwang J, Moon S, et al.
Expert Opin Biol Ther . 2024 Jun; 24(7):681-689. PMID: 38905143
Background: This study compared the pharmacokinetics (PK), immunogenicity, and safety of candidate tocilizumab biosimilar, CT-P47, administered via auto-injector (CT-P47 AI) or pre-filled syringe (CT-P47 PFS), in healthy Asian adults. Research...
4.
Yu J, Yang G, Oh H, Ryu Y
Curr Med Imaging . 2024 May; 20(1):e15734056300884. PMID: 38752631
Background: Columnar cell carcinoma is a rare subtype of papillary thyroid carcinoma (CCV-PTC) that accounts for only 0.15% to 0.2% of all Papillary Thyroid Carcinomas (PTCs). It has aggressive behavior...
5.
Ohk T, Cho J, Yang G, Ahn M, Lee S, Kim W, et al.
Am J Emerg Med . 2024 Jan; 78:132-139. PMID: 38271790
Introduction: Considering the few studies evaluating bystander cardiopulmonary resuscitation (CPR) performance, we sought to analyze differences in bystander CPR performance with and without the use of our self-developed animated GIFs...
6.
Yu K, Kim B, Shin D, Park M, Hwang J, Kim M, et al.
Expert Opin Investig Drugs . 2023 May; 32(5):429-439. PMID: 37231670
Background: CT-P47 is a candidate tocilizumab biosimilar. This study assessed the pharmacokinetic (PK) equivalence of CT-P47 and European Union-approved reference tocilizumab (EU-tocilizumab) in healthy Asian adults. Research Design And Methods:...
7.
Bae D, Park D, Lee S, Yang G, Kyung J, Kim D, et al.
Stem Cells Int . 2016 Jul; 2016:4079863. PMID: 27429621
Since multiple sclerosis (MS) is featured with widespread demyelination caused by autoimmune response, we investigated the recovery effects of F3.olig2 progenitors, established by transducing human neural stem cells (F3 NSCs)...
8.
Park D, Lee S, Bae D, Yang Y, Yang G, Kyung J, et al.
Cell Med . 2016 Feb; 5(1):17-28. PMID: 26858861
Improving the effects of human adipose tissue-derived mesenchymal stem cells (ASCs) on the demyelination and neurobehavioral function was investigated in an experimental model of neonatal hypoxic-ischemic encephalopathy (HIE). Seven-day-old male...
9.
Yang G, Park D, Lee S, Bae D, Yang Y, Kyung J, et al.
Biomol Ther (Seoul) . 2014 Jan; 21(6):454-61. PMID: 24404336
The neuroprotective effects of a butanol fraction of white rose petal extract (WRPE-BF) were investigated in a middle cerebral artery occlusion (MCAO) model. Seven week-old male rats were orally administered...
10.
Park D, Yang Y, Bae D, Lee S, Yang G, Kyung J, et al.
Neurobiol Aging . 2013 Jun; 34(11):2639-46. PMID: 23731954
Aging is characterized by progressive loss of cognitive and memory functions as well as decrease in physical activities. In the present study, a human neural stem cell line (F3 NSC)...